不同剂量阿托伐他汀对冠心病冠状动脉搭桥术患者术后血脂和心功能的影响被引量：5

The effect of different doses of atorvastatin on cardiac function and lipid in the patients with coronary heart disease after coronary artery bypass grafting

暂未订购

导出

摘要目的：观察冠心病冠状动脉搭桥术（ CABG）患者治疗前后应用不同剂量阿托伐他汀对术后血脂及心功能的影响。方法：将60例拟行CABG治疗的冠心病患者根据手术前后阿托伐他汀使用的剂量不同分为强化治疗组（40 mg/d）和常规治疗组（20 mg/d）各30例。比较2组患者治疗前后血脂及超声心动图检查结果，并记录用药期间不良反应。结果：强化治疗组治疗后总胆固醇、三酰甘油和低密度脂蛋白胆固醇降低程度及高密度脂蛋白胆固醇升高程度均优于常规治疗组（ P＜0.05-P＜0.01）。强化治疗组治疗后左心室收缩末期容积指数、左心室舒张末期容积指数和A峰降低程度及E峰、E/A与左心室射血分数升高程度均优于常规治疗组（P＜0.01）。强化治疗组总不良反应率为16.67%，常规治疗组为10.00%，差异无统计学意义（P〉0.05）。结论：冠心病CABG患者治疗前后应用阿托伐他汀强化治疗可显著调节血脂、改善心功能，效果优于常规剂量，且并不增加不良反应，安全有效。 Objective：To explore the effects of different doses of atorvastatin on the cardiac function and lipid in the patients with coronary heart disease after coronary artery bypass grafting（ CABG） . Methods：Sixty patients with coronary artery disease scheduled by CABG were randomly divided into the intensive treatment group（40 mg/d） and conventional treatment group（20 mg/d） according to the dose of atorvastatn before and after the surgery（30 cases each group）. The blood lipid level and echocardiographic finding between two groups were compared before and after surgery,and the adverse reactions in two groups were recorded during treatment. Results：After treatment,the reduction of total cholesterol,triglyceride and low-density lipoprotein-cholesterol and increasing degree of high-density lipoprotein-cholesterol in intensive treatment group were better than those in conventional treatment group（P 〈0. 05 to P 〈0. 01）. After treatment,the reduction of left ventricular end systolic volume index,left ventricular end-diastolic volume index and A peak and increasing degree of E peak,E/A and left ventricular ejection fraction in intensive treatment group were better than those in conventional treatment group（P〈0. 01）. The adverse reaction rates in intensive treatment group and conventional treatment group were 16. 67% and 10. 00%,respectively,the difference of which was not statistically significant（P〉0. 05）. Conclusions：The application of atorvastatin in the treatment of the coronary heart disease patients treated with CABG before and after surgery can significantly regulate blood lipid and improve heart function,which does not increase adverse reactions,and is safe and effective.

作者王平善

机构地区桂林医学院附属医院心胸外科

出处《蚌埠医学院学报》 CAS 2015年第6期746-748,共3页 Journal of Bengbu Medical College

关键词冠心病阿托伐他汀冠状动脉搭桥术血脂心功能 coronary artery disease atorvastatin coronary artery bypass grafting lipid cardiac function

分类号 R541.4 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献8

1Antoniades C, Bakogiannis C, Tousoulis D, et al. Preoperative atorvastatin treatment in CABG patients rapidly improves vein graft redox state by inhibition of Racl and NADPH-oxidase activity[ J ]. Circulation,2010,122( 11 Suppl) :S66 - S73.
2Brilakis ES,de-Lemos JA, Cannon CP, et al. Outcomes of patients with acute coronary syndrome and previous coronary artery bypass grafting (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy (PROVE IT-TIMI 22 ) and the Aggrastat to Zocor ( A to Z) trials) [ J ]. J Am Coil Cardiol, 2008,102 (5) : 552 -558.
3张文,张勤斌,胡大清.大剂量阿托伐他汀用于冠状动脉旁路移植术临床观察[J].中国药师,2011,14(7):1021-1022. 被引量：5
4Ege E, Dereli Y, Kurban S, et al. Atorvastatin pretreatment diminishes the levels of myocardial ischemia markers early after CABG operation : an observational study [ J]. J Cardiothorac Surg, 2010,5:60.
5Ji Q, Mei Y, Wang X, et al. Effect of preoperative atorvastatin therapy on atrial fibrillation following off-pump coronary artery bypass grafting. [ J ]. Circ J,2009,73 ( 12 ) :2244 - 2249.
6许力壮,单爱军,刘海华,罗滨.不同剂量阿托伐他汀对冠心病患者冠脉搭桥术后血脂和心功能的影响[J].中国老年学杂志,2013,33(23):5789-5791. 被引量：34
7艾阳平,马坚,赵可辉.实时三维超声心动图评价高血压左心室舒张功能的研究[J].中国临床医学影像杂志,2010,21(12):886-889. 被引量：6
8Sun Y, Qi G, Gao Y, et al. Effect of different loading doses of atorvastatin on percutaneous coronary intervention for acute coronary syndromes[J]. Can J Cardiol,2010,26(9) :481 -485.

二级参考文献28

1费洪文,何亚乐,梁志敏,侯跃双,许燕,黄新胜,冯碧霞.实时三维超声心动图容积-时间曲线评价左心室舒张功能的初步研究[J].中华超声影像学杂志,2006,15(1):9-12. 被引量：33
2Cerqueira MD,Weissman NJ,Dilsizian V,et al.Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart.A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association[J].Int J Cardiovasc Imaging,2002,18(1):539-542.
3Aurigemma GP,Gaasch WH.Clinical practice.Diastolic heart failure[J].N Engl J Med,2004,351(11):1097-1105.
4Stefanadis C,Manolis A,Dernellis J,et al.Acute effect of clonidine on left ventricular pressure -volume relation in hypertensive patients with diastolic heart dysfunction[J].J Hum Hypertens,2001,15(9):635-642.
5Alizadeh A,Maleki M,Bassiri H,et al.Evaluation of atrial thrombus formation and atrial appendage function in patients with pacemaker by transesophageal echocardiography[J].Pacing Clin Electrophysiol,2006,29(11):1251-1254.
6Eagle KA, Guyton RA, Davidoff R, et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery : summary article: a re- port of the American College of Cardiology/American Heart Associa- tion Task Force on Practice Guidelines [ J ]. Circul.ation, 2004, 110 (9) :1168-1176.
7Waters DD, Guyton JR, Herrington DM ,et al. Treating to New Targets (TNT) Study: does lowering low-density lipoprotein cholesterol levels below currently recommended guidelines yield incremental clinical benefit? [J]. Am J Cardiol,2004 ,93( 2 ) :154-158.
8Wenger NK, Lewis SJ, Herrington DM, et al. Outcomes of using high- or low-dose atorvastatin in patients 65 years of age or older with stable coronary heart disease[ J]. Ann Intern Med,2007,147 (1) :1-9.
9Schoonjans K, Peinado-Onsurbe J, Fruchart JC, et al. 3-Hydroxy-3- meth- ylglutaryl CoA reductase inhibitors reduce serum triglyceride levels through modulation of apolipoprotein C-Ill and lipoprotein lipase [ J]. FEBS Lett,1999,452(3) : 160-4.
10Landmesser U, Bahlmann F, Mueller M, et al. Simvastatin versus ezetimi- be: pleiotropic and lipid-lowering effects on endothelial function in hu- mans[ J]. Circulation ,2005 , 111 ( 18 ) :2356-63.